These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24917961)

  • 41. The role of endoscopy in the evaluation of fistulizing Crohn's disease.
    Regueiro M
    Gastrointest Endosc Clin N Am; 2002 Jul; 12(3):621-33. PubMed ID: 12486948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical Model of Perianal Fistulizing Crohn's Disease.
    Flacs M; Collard M; Doblas S; Zappa M; Cazals-Hatem D; Maggiori L; Panis Y; Treton X; Ogier-Denis E
    Inflamm Bowel Dis; 2020 Apr; 26(5):687-696. PubMed ID: 31774918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of medical treatment on patients with fistulizing Crohn's disease: a retrospective study.
    Uza N; Nakase H; Ueno S; Inoue S; Mikami S; Tamaki H; Matsuura M; Chiba T
    Intern Med; 2008; 47(4):193-9. PubMed ID: 18277016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
    Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
    J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of infliximab combined with surgical treatment of fistulizing perianal Crohn's disease: Comparative analysis according to fistula subtypes.
    Park EJ; Song KH; Baik SH; Park JJ; Kang J; Lee KY; Goo JI; Kim NK
    Asian J Surg; 2018 Sep; 41(5):438-447. PubMed ID: 28851611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disappointing durable remission rates in complex Crohn's disease fistula.
    Molendijk I; Nuij VJ; van der Meulen-de Jong AE; van der Woude CJ
    Inflamm Bowel Dis; 2014 Nov; 20(11):2022-8. PubMed ID: 25159455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review article: treatment of perianal fistulizing Crohn's disease.
    Rutgeerts P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():106-10. PubMed ID: 15352905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Managing perianal Crohn's fistula in the anti-TNFα era.
    Tozer P; Borowski DW; Gupta A; Yassin N; Phillips R; Hart A
    Tech Coloproctol; 2015 Nov; 19(11):673-8. PubMed ID: 26264168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adalimumab - an effective and promising treatment for patients with fistulizing Crohn's disease: a case series.
    Kouklakis G; Efremidou EI; Zezos P; Liratzopoulos N; Souftas VD; Gatopoulou A; Simopoulos K; Manolas KJ
    J Med Case Rep; 2011 Mar; 5():109. PubMed ID: 21418588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Perianal Fistula and Abscess: Crohn's and Non-Crohn's.
    Mardini HE; Schwartz DA
    Curr Treat Options Gastroenterol; 2007 Jun; 10(3):211-20. PubMed ID: 17547859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
    van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG
    Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and complications of surgery for Crohn's disease.
    Lewis RT; Maron DJ
    Gastroenterol Hepatol (N Y); 2010 Sep; 6(9):587-96. PubMed ID: 21088749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-TNF and fistulizing perianal Crohn's disease: use in clinical practice.
    Bourikas LA; Koutroubakis IE
    Curr Drug Targets; 2010 Feb; 11(2):187-97. PubMed ID: 19916954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of fistulizing Crohn's disease.
    Lichtenstein GR
    Gastroenterology; 2000 Oct; 119(4):1132-47. PubMed ID: 11040200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands.
    Baars JE; Kuipers EJ; Dijkstra G; Hommes DW; de Jong DJ; Stokkers PC; Oldenburg B; Pierik M; Wahab PJ; van Bodegraven AA; van der Woude CJ;
    Scand J Gastroenterol; 2011 Mar; 46(3):319-25. PubMed ID: 21299339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Zhu M; Xu X; Feng Q; Cui Z; Wang T; Yan Y; Ran Z
    Dig Dis Sci; 2021 May; 66(5):1658-1668. PubMed ID: 32524415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant human granulocyte-macrophage colony stimulating factor (sargramostim) as an alternative therapy for fistulizing Crohn's disease.
    Magno P; Jiménez CE; Ortiz Z; Torres EA
    P R Health Sci J; 2010 Mar; 29(1):60-5. PubMed ID: 20222336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn's disease patients.
    Papa A; Lopetuso LR; Minordi LM; Di Veronica A; Neri M; Rapaccini G; Gasbarrini A; Papa V
    Expert Rev Gastroenterol Hepatol; 2020 Sep; 14(9):857-865. PubMed ID: 32673498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydrogen peroxide enhanced ultrasound- fistulography in the assessment of enterocutaneous fistulas complicating Crohn's disease.
    Maconi G; Parente F; Bianchi Porro G
    Gut; 1999 Dec; 45(6):874-8. PubMed ID: 10562586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.